Pharmacological management of narcolepsy in children and adolescents
- PMID: 38050449
- DOI: 10.1111/jsr.14055
Pharmacological management of narcolepsy in children and adolescents
References
REFERENCES
-
- Bassetti, C. L. A., Kallweit, U., Vignatelli, L., Plazzi, G., Lecendreux, M., Baldin, E., Dolenc‐Groselj, L., Jennum, P., Khatami, R., Manconi, M., Mayer, G., Partinen, M., Pollmächer, T., Reading, P., Santamaria, J., Sonka, K., Dauvilliers, Y., & Lammers, G. J. (2021). European guideline and expert statements on the management of narcolepsy in adults and children. European Journal of Neurology, 28, 2815–2830.
-
- Dauvilliers, Y., Lecendreux, M., Lammers, G. J., Franco, P., Poluektov, M., Caussé, C., Lecomte, I., Lecomte, J.‐M., Lehert, P., Schwartz, J.‐C., & Plazzi, G. (2023). Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: A double‐blind, randomised, placebo‐controlled trial. Lancet Neurology, 22, 303–311.
-
- Lecendreux, M., Bruni, O., Franco, P., Gringras, P., Konofal, E., Nevsimalova, S., Paiva, T., Partinen, M., Peeters, E., Peraita‐Adrados, R., Plazzi, G., & Poli, F. (2012). Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. Journal of Sleep Research, 21(4), 481–483.
-
- Plazzi, G., Clawges, H. M., & Owens, J. A. (2018). Clinical characteristics and burden of illness in pediatric patients with narcolepsy. Pediatric Neurology, 85, 21–32.
-
- Postiglione, E., Antelmi, E., Pizza, F., Lecendreux, M., Dauvilliers, Y., & Plazzi, G. (2018). The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews, 38, 70–85.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources